Conferences

featured article image

Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Heather Moore, CPP, PharmD and 1 other

Read HER2-Low, A Separate Entity?

Link to David Rimm MD-PhD's page

HER2-Low, A Separate Entity?

David Rimm MD-PhD

Dec 18, 2022 Link to HER2-Low, A Separate Entity?

Read Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Link to Katharine Yao, MD's page

Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Katharine Yao, MD

Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Read HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Link to Kalliopi Siziopikou, MD PhD's page

HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Kalliopi Siziopikou, MD PhD

Dec 18, 2022 Link to HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Read Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Link to Kimberly J. Van Zee, MS, MD, FACS's page

Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Kimberly J. Van Zee, MS, MD, FACS

Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Read AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Link to Jordan Axelrad, MD, MPH's page

AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Jordan Axelrad, MD, MPH

Dec 11, 2022 Link to AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Read A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Link to Alan Colm Moss, MD FACG, AGAF, FEBG, FRCPI's page

A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Alan Colm Moss, MD FACG, AGAF, FEBG, FRCPI

Dec 11, 2022 Link to A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Read Steroids: Never or Forever

Link to Raymond Keith Cross Jr., MD MS, AGAF, FACG's page

Steroids: Never or Forever

Raymond Keith Cross Jr., MD MS, AGAF, FACG

Dec 11, 2022 Link to Steroids: Never or Forever

Read ASH 2022: Sickle Cell Disease in the Big Easy

ASH 2022: Sickle Cell Disease in the Big Easy

Seethal A. Jacob, MD MS and 1 other

Dec 5, 2022 Link to ASH 2022: Sickle Cell Disease in the Big Easy

Read RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Link to Douglas Katz, MD's page

RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Douglas Katz, MD

Dec 5, 2022 Link to RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Read ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Link to Burton Eliot Appel, MD ,MBA's page

ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Burton Eliot Appel, MD ,MBA

Dec 5, 2022 Link to ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Read Preview of The 64th American Society of Hematology Annual Meeting

Link to Reshma Ramlal, MD FACP's page

Preview of The 64th American Society of Hematology Annual Meeting

Reshma Ramlal, MD FACP

Dec 5, 2022 Link to Preview of The 64th American Society of Hematology Annual Meeting

Read Attending My 30th RSNA Annual Meeting

Link to C. Douglas Phillips, MD FACR's page

Attending My 30th RSNA Annual Meeting

C. Douglas Phillips, MD FACR

Dec 5, 2022 Link to Attending My 30th RSNA Annual Meeting

Read ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Link to Camila Masias, MD's page

ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Camila Masias, MD

Dec 5, 2022 Link to ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Read ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Link to Shakira J. Grant, MD's page

ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Shakira J. Grant, MD

Dec 5, 2022 Link to ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Read ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Link to Marc Braunstein, MD PhD FACP's page

ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Marc Braunstein, MD PhD FACP

Dec 1, 2022 Link to ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Read Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity

Link to Basil Michael Kahwash, MD's page

Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity

Basil Michael Kahwash, MD

Nov 21, 2022 Link to Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity

Read ACR Convergence 2022 – Philadelphia

Link to Thomas P. Olenginski, MD FACP's page

ACR Convergence 2022 – Philadelphia

Thomas P. Olenginski, MD FACP

Nov 20, 2022 Link to ACR Convergence 2022 – Philadelphia

Read Gender-Based Differences in axSpA: Biology or Study Design?

Link to Marina Magrey, MD's page

Gender-Based Differences in axSpA: Biology or Study Design?

Marina Magrey, MD

Nov 20, 2022 Link to Gender-Based Differences in axSpA: Biology or Study Design?

Read Evidence-Based Medicine is Not Evident in the New American College of Rheumatology Guidelines for Glucocorticoid-Induced Osteoporosis

Link to Robin Dore, MD's page

Evidence-Based Medicine is Not Evident in the New American College of Rheumatology Guidelines for Glucocorticoid-Induced Osteoporosis

Nov 20, 2022 Link to Evidence-Based Medicine is Not Evident in the New American College of Rheumatology Guidelines for Glucocorticoid-Induced Osteoporosis

Read A Vast Array of Eye-Opening Studies Were Featured at ACR 2022

Link to David A. McLain, MD, MACR, FACP's page

A Vast Array of Eye-Opening Studies Were Featured at ACR 2022

David A. McLain, MD, MACR, FACP

Nov 20, 2022 Link to A Vast Array of Eye-Opening Studies Were Featured at ACR 2022

Read Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus Nephritis

Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus Nephritis

Kenneth Kalunian, MD and 1 other

Nov 20, 2022 Link to Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus Nephritis